Literature DB >> 26899278

The increase in the rate of maternal deaths related to cardiovascular disease in Japan from 1991-1992 to 2010-2012.

Hiroaki Tanaka1, Shinji Katsuragi2, Kazuhiro Osato3, Junichi Hasegawa4, Masahiko Nakata5, Takeshi Murakoshi6, Jun Yoshimatsu7, Akihiko Sekizawa4, Naohiro Kanayama8, Isamu Ishiwata9, Tomoaki Ikeda10.   

Abstract

BACKGROUND: Cardiovascular diseases (CVD), both genetic and acquired, increase the risk of maternal death (MD) unless proper genetic/clinical counseling is provided and a multidisciplinary approach is adopted during pregnancy. In recent decades, there has been a significant increase in the number of women with CVD of child-bearing age and in the incidence of pregnancy among relatively older women. However, the impact of this phenomenon on MD has not been carefully investigated.
METHODS: This retrospective study compares the incidence and etiology of maternal deaths related to cardiovascular disease (MD-CVD) in Japan in 2010-2012 to that seen in 1991-1992.
RESULTS: Seven cases of MD-CVD were reported in 1991-1992, compared to 15 in 2010-2012. In 2010-2012, the causes included aortic dissection (n=5), peripartum cardiomyopathy (n=3), sudden adult/arrhythmic death syndrome (n=2), acute cardiomyopathy (n=2), pulmonary hypertension (n=2), and myocardial infarction (n=1), and four of these causes were not encountered in 1991-1992. The incidence of MD over the total number of pregnancies decreased from 9.4 per 100,000 cases in 1990-1992 to 4.6 per 100,000 cases in 2010-2012 (p<0.05). However, the incidence of MD-CVD over the number of cases of MD increased from 2.9% in 1991-1992 to 9.7% in 2010-2012 (p<0.05).
CONCLUSIONS: The present study demonstrates that the rate of MD-CVD among the cases of MD has increased 3-fold in Japan over the past 20 years. Thus, it is of critical importance to better understand the etiologies and early signs of MD-CVD and to devise an effective management program for pregnancies complicated by CVD.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Maternal death; Pregnancy

Mesh:

Year:  2016        PMID: 26899278     DOI: 10.1016/j.jjcc.2016.01.005

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  6 in total

Review 1.  ECG and arrhythmias in peripartum cardiomyopathy.

Authors:  David Duncker; Tobias J Pfeffer; Johann Bauersachs; Christian Veltmann
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-03-31

2.  In-hospital management and outcomes in patients with peripartum cardiomyopathy: a descriptive study using a national inpatient database in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2017-02-23       Impact factor: 2.037

3.  Clinical features and peripartum outcomes in pregnant women with cardiac disease: a nationwide retrospective cohort study in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Akira Kohyama; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2018-02-17       Impact factor: 2.037

4.  Decline in maternal death due to obstetric haemorrhage between 2010 and 2017 in Japan.

Authors:  Junichi Hasegawa; Shinji Katsuragi; Hiroaki Tanaka; Akiko Kurasaki; Masamitsu Nakamura; Takeshi Murakoshi; Masahiko Nakata; Naohiro Kanayama; Akihiko Sekizawa; Ishiwata Isamu; Katsuyuki Kinoshita; Tomoaki Ikeda
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

5.  Effect of maternal positioning during cardiopulmonary resuscitation: a systematic review and meta-analyses.

Authors:  Naosuke Enomoto; Tomoyuki Yamashita; Marie Furuta; Hiroaki Tanaka; Edmond S W Ng; Shigetaka Matsunaga; Atsushi Sakurai
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-25       Impact factor: 3.007

6.  Risk Factors for Cardiovascular Events among Pregnant Women with Cardiovascular Disease.

Authors:  Masafumi Nii; Hiroaki Tanaka; Kayo Tanaka; Shinji Katsuragi; Chizuko A Kamiya; Yumi Shiina; Koichiro Niwa; Tomoaki Ikeda
Journal:  Intern Med       Date:  2020-05-01       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.